Clinical Research Directory
Browse clinical research sites, groups, and studies.
INTERACT4 Expansion - Validation Study
Sponsor: The George Institute
Summary
As an investigator-initiated and conducted, multi-centre, open-label, single-arm prospective observational trial, INTERACT4 Expansion aims to evaluate the feasibility of setting up and conducting a trial that uses a point-of-care GFAP test to identify ICH in patients presenting with acute stroke-like symptoms in the pre-hospital setting.
Official title: INTEnsive Ambulance-delivered Blood Pressure Reduction in Biomarker-identified Hyper-ACute Intracerebral Haemorrhage Trial - Validation Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
163
Start Date
2026-09-18
Completion Date
2027-06-01
Last Updated
2026-10-26
Healthy Volunteers
No
Conditions
Interventions
LVOne
LVOne is an in vitro diagnostic rapid lateral flow chromatographic immunoassay kit
Locations (6)
Liverpool Hospital
Sydney, New South Wales, Australia
Nepean Hospital
Sydney, New South Wales, Australia
New South Wales Ambulance
Sydney, New South Wales, Australia
Royal North Shore Hospital
Sydney, New South Wales, Australia
St George Hospital
Sydney, New South Wales, Australia
Wollongong Hospital
Sydney, New South Wales, Australia